Two mixed-NH3/amine platinum (II) anticancer complexes featuring a dichloroacetate moiety in the leaving group

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Liu, Weiping ^a   Su, Jia ^b,c   Jiang, Jing ^a   Li, Xingyao ^b,c   Ye, Qingsong ^a   Zhou, Hongyu ^b   Chen, Jialin ^a   Li, Yan ^b  

^a KUNMING INSTITUTE OF PRECIOUS METALS   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AMMONIA; ANTINEOPLASTIC AGENT; CHLOROACETIC ACID; PLATINUM DERIVATIVE;

APOPTOSIS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; TUMOR CELL LINE; ARTICLE; DRUG EFFECT; EXPERIMENTAL NEOPLASM;

AMINES; AMMONIA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CHLOROACETATES; HUMANS; NEOPLASMS, EXPERIMENTAL; PLATINUM COMPOUNDS;

EID: 84883124407     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02464     Document Type: Article

References (20)

1. Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7, 573-584 (2007). (Pubitemid 47106628)
2. Harper, B. W. et al. Advances in platinum chemotherapeutics. Chem. Eur. J. 16, 7064-7077 (2010).
3. Rabik, C. A. & Dolan, M. E. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat. Rev. 33, 9-23 (2007). (Pubitemid 46137553)
4. Wang, D. & Lippard, S. J. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 4, 307-320 (2005). (Pubitemid 41130944)
5. Galanski, M., Jakupec, M. A. & Keppler, B. K. Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches. Curr. Med. Chem. 12, 2075-2094 (2005). (Pubitemid 41093559)
6. Hartinger, C. G., Nazarov, A. A., Ashraf, S. M., Dyson, P. J. & Keppler, B. K. Carbohydrate-metal complexes and their potential as anticancer agents. Curr. Med. Chem. 15, 2574-2591 (2008).
7. Zhao, J., Gou, S., Sun, Y., Fang, L. & Wang, Z. Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity. Inorg. Chem. 51, 10317-10324 (2012).
8. Zhao, J., Gou, S., Sun, Y., Yin, R. & Wang, Z. Nitric oxide donor-based platinum complexes as potential anticancer agents. Chem. Eur. J. 18, 14276-14281 (2012).
9. Dhar, S. & Lippard, S. J. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate. Proc. Natl. Acad. Sci. U. S. A. 106, 22199-22204 (2009).
10. Stacpoole, P. W. et al. Controlled clinical trials of dichloroacetate for treatment of congenital lactic acidosis in children. Padiatrics 117, 1519-1531 (2006). (Pubitemid 46071378)
11. Wong, J. Y., Huggins, G. S., Debidda, M., Munshi, N. C. & De Vivo, I. Dichloroacetate induces apoptosis in endometrial cancer cells. Gynecol. Oncol. 109, 394-402 (2008).
12. Madhok, B. M., Yeluri, S., Perry, S. L., Hughes, T. A. & Jayne, D. G. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells. British Journal of Cancer 102, 1746-1752 (2010).
13. Pearson, H. Cancer patients opt for unapproved drug. Nature 446, 474-475 (2007). (Pubitemid 46514699)
14. Coglan, A. Cheap, 'safe' drug kills most cancers. New Scientist 20 January 2007.
15. Xiao, H. et al. A dual-targeting hybrid platinum (IV) prodrug for enhancing efficacy. Chem.Commun. 48, 10730-10732 (2012).
16. Giandomenico, C. M. et al. Synthesis and reactions of a newclass of orally active Pt (IV) antitumor complexes. In: Howell, S. B. (ed.). Platinum and Other Metal Coordination Complexes in Cancer Chemotherapy, pp. 93-100. New York: Plenum Publishing Corp. (1991).
17. Drees, M., Dengler, W. M., Hendriks, H. R., Kelland, L. R. & Fiebig, H. H. Cycloplatam: a novel platinum compound exhibiting a different spectrum ofanti-tumour activity to cisplatin. Eur. J. Cancer 31, 356-361 (1995).
18. Poont, G. K., Mistry, P. & Lewis, S. Electrospray ionization mass spectrometry of platinum anticancer agents. Biol. Mass Spectrom. 20, 687-692 (1991).
19. Liu, W. et al. A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity. Inorg. Chem. 50, 5324-5326 (2011).
20. Liu, W. et al. 3-Hydroxycarboplatin, a simple carboplatin derivative endowed with an improved toxicological profile. Platinum Met. Rev. 56, 248-256 (2012).